Latest Boardroom Shifts News

Mindax ended FY2026 with just A$83,116 in cash and a A$2.49 million loss before tax, prompting its auditor to highlight material uncertainty over the company’s ability to continue as a going concern. Post-year-end funding has lifted cash to A$4.079 million, although much of that support remains tied to convertible debt and approvals.

Charter Hall Retail REIT has set a floor of 3.5% growth for FY27 operating earnings and distributions, while its chair acknowledged the units are trading below net tangible assets. The convenience property group enters the year with 99.1% occupancy, lower debt margins and a portfolio evenly split between shopping centres and net lease assets.

Orion Minerals has moved Prieska’s Uppers Mine closer to construction after Glencore’s US$40 million Tranche A financing became unconditional. The company ended September with A$9.62 million in cash, while the larger US$210 million Tranche B package remains conditional.

AVA Risk Group has opened FY27 with A$6.7 million in quarterly bookings and a 1.2 book-to-bill ratio, while acknowledging that FY26 revenue and profitability fell short of expectations. The company is betting that sharper commercial discipline, US expansion and a broader solutions model can turn a large pipeline into more dependable growth.

Beforepay Group will replace CEO Jamie Twiss with deputy CEO Kasey Kaplan on 7 December, making an internal succession change as the fintech enters its next growth phase. Kaplan’s package includes A$600,000 fixed remuneration, annual incentives, equity rights and a potential six-year milestone plan worth up to A$10 million.

Challenger Gold has reset its Hualilan strategy around a larger integrated mine after ending the Casposo toll-milling campaign, while new debt funding extends the project’s runway. The company is targeting early 2029 production, but only A$25.8 million was held in cash at quarter-end and part of the proposed financing remains conditional.

INOVIQ will restart its EXO-OC ovarian cancer program through a staged optimisation and verification process after an independent review found sample collection and handling were the main sources of variability. The company is targeting US laboratory-developed test readiness in the first half of 2028, while a leadership change adds another moving part.

PainChek is concentrating its commercial effort on residential aged care after signing new US and UK business, including an 808-licence Sabra expansion and an approximately 1,800-licence Hallmark contract. Revenue and retention improved, but activated ARR growth slowed to 1.2% for the quarter and cash covered an estimated 2.5 quarters of historical operating outflows.

Biotron’s BIT-HBV001 produced up to a 99.7% reduction in HBV-DNA in cell-based studies, while combination testing with Myrcludex B showed antiviral synergy. The company is also refining SedRx’s European regulatory pathway, but had A$1.06 million in cash at quarter-end, equivalent to 2.15 quarters of funding at the latest operating burn rate.

Cazaly Resources has secured a 51% stake in the Goongarrie Gold Project a year ahead of schedule, while early Hastings drilling extended anomalous gold mineralisation along the Bardoc Tectonic Zone. The explorer is now testing another historical target at Gulls Blow as a new managing director begins a review of the wider portfolio.

Zimi has moved its next-generation Matter smart-home range closer to certification and production, while securing access to more than 10,000 retail outlets through Directed. But the company ended September with $344,000 in cash after burning $714,000 on operations, leaving further funding firmly in the frame.

South Port has entered FY27 with record full-year earnings behind it and first-quarter cargo volumes still rising, while a new chair takes over during a fresh investment cycle. The port is also preparing to add staff and potentially replace major equipment as regional development opportunities build.